606 related articles for article (PubMed ID: 29777252)
21. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.
Chen H; Hu W; He H; Yang Y; Wen G; Lv X
Eur J Radiol; 2019 May; 114():152-159. PubMed ID: 31005167
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
23. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
24. [Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling in Ki-67 labeling index and grading of brain gliomas].
Wang CC; Dong HB; Ding F; Li YD; Wang GY; Ding HX
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):338-342. PubMed ID: 30772973
[No Abstract] [Full Text] [Related]
25. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models.
Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A
Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427
[TBL] [Abstract][Full Text] [Related]
26. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
[TBL] [Abstract][Full Text] [Related]
27. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.
Sun Y; Su C; Deng K; Hu X; Xue Y; Jiang R
Eur Radiol; 2022 Jun; 32(6):3744-3754. PubMed ID: 35076759
[TBL] [Abstract][Full Text] [Related]
28. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
[TBL] [Abstract][Full Text] [Related]
29. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI.
Wang X; Chen XZ; Shi L; Dai JP
Clin Radiol; 2019 Aug; 74(8):651.e7-651.e14. PubMed ID: 31014573
[TBL] [Abstract][Full Text] [Related]
30. Anatomical location differences between mutated and wild-type isocitrate dehydrogenase 1 in low-grade gliomas.
Yu J; Shi Z; Ji C; Lian Y; Wang Y; Chen L; Mao Y
Int J Neurosci; 2017 Oct; 127(10):873-880. PubMed ID: 27929688
[TBL] [Abstract][Full Text] [Related]
31. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of
Park YW; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Kang SG; Kim EH; Lee SK
AJNR Am J Neuroradiol; 2018 Apr; 39(4):693-698. PubMed ID: 29519794
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging.
Liu S; Zhang Y; Kong Z; Jiang C; Wang Y; Zhao D; You H; Ma W; Feng F
BMC Neurosci; 2022 Dec; 23(1):72. PubMed ID: 36471242
[TBL] [Abstract][Full Text] [Related]
33. The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas.
Niu L; Feng WH; Duan CF; Liu YC; Liu JH; Liu XJ
Biomed Res Int; 2020; 2020():4630218. PubMed ID: 33163535
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging.
Lee S; Choi SH; Ryoo I; Yoon TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH
J Neurooncol; 2015 Jan; 121(1):141-50. PubMed ID: 25205290
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of perfusion- and diffusion-weighted imaging to differentiate between pilocytic astrocytomas and high-grade gliomas: a multicenter study in Japan.
Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Kamei R; Kitajima M; Kanoto M; Takahashi H; Uchiyama Y; Harada M; Shinohara Y; Yoshiura T; Wakata Y; Honda H
Neuroradiology; 2018 Apr; 60(4):391-401. PubMed ID: 29450601
[TBL] [Abstract][Full Text] [Related]
36. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.
Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y
Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160
[TBL] [Abstract][Full Text] [Related]
38. Intravoxel incoherent motion magnetic resonance imaging in predicting IDH1 gene mutations in high-grade gliomas.
Wang C; Dong H
Acta Radiol; 2021 Oct; 62(10):1412-1417. PubMed ID: 33951927
[TBL] [Abstract][Full Text] [Related]
39. Advanced MR imaging and
Piccardo A; Tortora D; Mascelli S; Severino M; Piatelli G; Consales A; Pescetto M; Biassoni V; Schiavello E; Massollo M; Verrico A; Milanaccio C; Garrè ML; Rossi A; Morana G
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1685-1694. PubMed ID: 31030232
[TBL] [Abstract][Full Text] [Related]
40. Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes.
Guo H; Kang H; Tong H; Du X; Liu H; Tan Y; Yang Y; Wang S; Zhang W
Eur Radiol; 2019 Apr; 29(4):1893-1902. PubMed ID: 30276676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]